| Head trauma in a community-based sample of victims of intimate partner violence: prevalence, mechanisms of injury and symptom presentation JE Meyer, V Jammula, PA Arnett Journal of interpersonal violence 37 (17-18), NP15255-NP15274, 2022 | 20 | 2022 |
| Living with a central nervous system (CNS) tumor: findings on long-term survivorship from the NIH Natural History Study JL Rogers, E Vera, A Acquaye, N Briceno, V Jammula, AL King, H Leeper, ... Neuro-oncology practice 8 (4), 460-474, 2021 | 13 | 2021 |
| Effects of cognitive reserve on cognition in individuals with central nervous system disease VR Jammula, H Leeper, MR Gilbert, D Cooper, TS Armstrong Cognitive and Behavioral Neurology 34 (4), 245-258, 2021 | 9 | 2021 |
| Relationship between RANO-PRO Working Group standardised priority constructs and disease progression among malignant glioma patients: A retrospective cohort study E Vera, A Christ, E Grajkowska, N Briceno, A Choi, SK Crandon, K Wall, ... EClinicalMedicine 55, 2023 | 7 | 2023 |
| Exploring the prevalence and burden of sleep disturbance in primary brain tumor patients AL King, DD Shuboni-Mulligan, E Vera, S Crandon, AA Acquaye, L Boris, ... Neuro-oncology practice 9 (6), 526-535, 2022 | 7 | 2022 |
| The Montreal Cognitive Assessment (MoCA) in neuro-oncology: A pilot study of feasibility and utility in telehealth and in-person clinical assessments V Jammula, JL Rogers, E Vera, A Christ, HE Leeper, A Acquaye, ... Neuro-oncology practice 9 (5), 429-440, 2022 | 5 | 2022 |
| CTIM-32. Immune checkpoint inhibitor nivolumab in people with recurrent select rare cns cancers: Results of interim analysis in a heavily pretreated cohort M Penas-Prado, Y Yuan, K Wall, E Vera, U Ikiddeh-Barnes, K Blackburn, ... Neuro-Oncology 23 (Supplement_6), vi57-vi58, 2021 | 2 | 2021 |
| Association of employment status with symptom burden and health-related quality of life in people living with primary CNS tumors HE Leeper, E Vera, A Christ, A Acquaye, N Briceno, A Choi, E Grajkowska, ... Neurology 100 (16), e1723-e1736, 2023 | 1 | 2023 |
| QOLP-19. FINANCIAL TOXICITY AND DISTRESS DURING THE COVID-19 PANDEMIC IN PEOPLE LIVING WITH PRIMARY BRAIN TUMORS H Leeper, E Vera, A Acquaye, N Briceno, A Choi, A Christ, E Grajkowska, ... Neuro-Oncology 23 (Supplement_6), vi187-vi187, 2021 | 1 | 2021 |
| INNV-32. COMPARING THE MONTREAL COGNITIVE ASSESSMENT (MOCA) FULL AND 5-MINUTE PROTOCOLS IN MILD COGNITIVE IMPAIRMENT SCREENING OF ADULT CNS TUMOR PATIENTS Y Kim, J Rogers, V Jammula, E Vera, A Christ, H Leeper, A Acquaye, ... Neuro-Oncology 24 (Supplement_7), vii148-vii148, 2022 | | 2022 |
| Evaluation of the key geriatric assessment constructs in primary brain tumor population-a descriptive study D Sass, E Vera, A Choi, A Acquaye, N Briceno, A Christ, E Grajkowska, ... Journal of geriatric oncology 13 (8), 1194-1202, 2022 | | 2022 |
| NCOG-39. EXPLORING PATIENT REPORTED OUTCOMES (PROS) ACROSS ETHNORACIAL GROUPS IN PRIMARY BRAIN TUMOR (PBT) PATIENTS: DIFFERENCES IN THE ILLNESS EXPERIENCE A King, JDLC Minyety, A Acquaye, N Briceno, A Choi, A Christ, ... Neuro-Oncology 23 (Supplement_6), vi160-vi160, 2021 | | 2021 |
| NCOG-23. PATIENT-REPORTED SYMPTOM BURDEN AND INTERFERENCE: A COMPARISON BETWEEN COVID-19 PANDEMIC YEAR AND NORMATIVE DATA IN PATIENTS WITH CENTRAL NERVOUS SYSTEM (CNS) TUMORS V Pillai, L Polskin, E Vera, A Acquaye, N Briceno, A Choi, A Christ, ... Neuro-Oncology 23 (Supplement_6), vi156-vi157, 2021 | | 2021 |
| QOLP-33. EVIDENCE OF FINANCIAL TOXICITY IN PRIMARY CENTRAL NERVOUS SYSTEM TUMOR PATIENTS: CORRELATIONS BETWEEN EMPLOYMENT STATUS, SYMPTOM BURDEN AND HEALTH-RELATED QUALITY OF LIFE A Christ, E Vera, A Acquaye, N Briceno, A Choi, E Grajkowska, ... Neuro-Oncology 23 (Supplement_6), vi190-vi190, 2021 | | 2021 |
| NCOG-34. A DESCRIPTIVE ANALYSIS OF GLIOMATOSIS CEREBRI CASES, COMPARED ACCORDING TO IDH STATUS L Boris, E Vera, A Acquaye, N Briceno, A Choi, A Christ, E Grajkowska, ... Neuro-Oncology 23 (Supplement_6), vi159-vi159, 2021 | | 2021 |
| NCOG-18. RELATIONSHIP BETWEEN RANO-PRO WORKING GROUP STANDARDIZED PRIORITY CONSTRUCTS AND DISEASE PROGRESSION AMONG MALIGNANT GLIOMA PATIENTS AS MEASURED THROUGH CLINICAL … E Vera, T Mendoza, A Acquaye, N Briceno, A Choi, A Christ, ... Neuro-Oncology 23 (Supplement_6), vi155-vi156, 2021 | | 2021 |
| QOLP-37. MOOD DISTURBANCE IN PATIENTS WITH CENTRAL NERVOUS SYSTEM (CNS) TUMORS DURING THE COVID-19 PANDEMIC L Polskin, V Pillai, E Vera, A Acquaye, N Briceno, A Choi, A Christ, ... Neuro-Oncology 23 (Supplement_6), vi191-vi191, 2021 | | 2021 |
| INNV-27. AN INNOVATIVE VIRTUAL MULTI-INSTITUTIONAL, MULTIDISCIPLINARY NEURO-ONCOLOGY TUMOR BOARD: THE NIH-NOB EXPERIENCE DURING THE COVID-19 PANDEMIC J Rogers, A Acquaye, U Ikiddeh-Barnes, K Benson, L Boris, F Akindona, ... Neuro-oncology 23 (Supplement_6), vi111-vi111, 2021 | | 2021 |
| NCOG-43. RELATIONSHIPS BETWEEN MOOD DISTURBANCE, SYMPTOM INTERFERENCE, AND DISEASE PROGRESSION IN GLIOMA PATIENTS K Roche, E Vera, A Acquaye, N Briceno, A Choi, A Christ, E Grajkowska, ... Neuro-Oncology 23 (Supplement_6), vi161-vi161, 2021 | | 2021 |
| NCOG-47. CONGRUENCE BETWEEN PROVIDER REPORTED PERFORMANCE STATUS AND BOTH OBJECTIVE AND PERCEIVED COGNITION IN A GLIOMA POPULATION M Panzer, E Vera, A Acquaye, N Briceno, A Choi, A Christ, E Grajkowska, ... Neuro-Oncology 23 (Supplement_6), vi162-vi162, 2021 | | 2021 |
